Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods.

Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods.

To evaluate the potential value of using a serological assay to quantitate the hepatitis C virus core antigen (HCV-Ag) when monitoring patients with chronic hepatitis C being treated with direct-acting antivirals (DAAs).Ninety-six patients treated with DAAs, either alone (91) or in combination with...

Full description

Bibliographic Details
Main Authors: Elisabetta Loggi, Silvia Galli, Giovanni Vitale, Roberto Di Donato, Ranka Vukotic, Elena Grandini, Marzia Margotti, Valeria Guarneri, Giuliano Furlini, Claudio Galli, Maria Carla Re, Pietro Andreone
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5681287?pdf=render

Internet

http://europepmc.org/articles/PMC5681287?pdf=render

Similar Items